These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11387354)

  • 21. Discordance of p53 mutations of synchronous colorectal carcinomas.
    Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M
    Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome.
    Migliavacca M; Ottini L; Bazan V; Agnese V; Corsale S; Macaluso M; Lupi R; Dardanoni G; Valerio MR; Pantuso G; Di Fede G; Tomasino RM; Gebbia N; Mariani-Costantini R; Russo A
    J Cell Physiol; 2004 Sep; 200(3):476-85. PubMed ID: 15254976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas.
    Clausen OP; Lothe RA; Børresen-Dale AL; De Angelis P; Chen Y; Rognum TO; Meling GI
    Diagn Mol Pathol; 1998 Aug; 7(4):215-23. PubMed ID: 9917132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients.
    Kihana T; Hamada K; Inoue Y; Yano N; Iketani H; Murao S; Ukita M; Matsuura S
    Cancer; 1995 Jul; 76(1):72-8. PubMed ID: 8630879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
    Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.
    Dix BR; Robbins PD; Spagnolo DV; Padovan GL; House AK; Iacopetta BJ
    Diagn Mol Pathol; 1995 Dec; 4(4):261-5. PubMed ID: 8634782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
    McIntyre JF; Smith-Sorensen B; Friend SH; Kassell J; Borresen AL; Yan YX; Russo C; Sato J; Barbier N; Miser J
    J Clin Oncol; 1994 May; 12(5):925-30. PubMed ID: 8164043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
    De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
    Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal carcinoma prognosis can be predicted by alterations in gene p53 exons 5 and 8.
    Vidaurreta M; Maestro ML; Sanz-Casla MT; Rafael S; Veganzones S; de la Orden V; Cerdán J; Arroyo M; Torres A
    Int J Colorectal Dis; 2008 Jun; 23(6):581-6. PubMed ID: 18322661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases.
    Khan ZA; Jonas SK; Feldmann KA; Patel H; Wharton RQ; Tarragona A; Ivison A; Allen-Mersh TG
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):675-80. PubMed ID: 11710597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients.
    Ko JM; Cheung MH; Wong CM; Lau KW; Tang CM; Kwan MW; Lung ML
    Cancer Lett; 1998 Dec; 134(2):169-76. PubMed ID: 10025877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [p53 mutations and protein overexpression in primary colorectal cancer and its liver metastasis].
    Yang Y; Xia Q; Lian F
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):114-8. PubMed ID: 11776850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [p53 gene point mutation in human colorectal carcinoma].
    Xu W; Yang D; Wan Y
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):328-31. PubMed ID: 8697967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
    Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H
    Cancer; 2000 Jun; 88(12):2661-7. PubMed ID: 10870047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutations in urinary bladder cancer.
    Berggren P; Steineck G; Adolfsson J; Hansson J; Jansson O; Larsson P; Sandstedt B; Wijkström H; Hemminki K
    Br J Cancer; 2001 Jun; 84(11):1505-11. PubMed ID: 11384101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.